Form 4: Aramark Director Acquires 5,124 Deferred Stock Units
Insider Transaction Report
Aramark Director Susan M. Cameron acquired 5,124 deferred stock units at $38.06 per share, increasing her beneficial ownership.
Summary
- Susan M. Cameron, a Director of Aramark (ARMK), acquired 5,124 shares of common stock in the form of deferred stock units.
- The transaction occurred on February 3, 2026, with a price of $38.06 per share.
- Following this acquisition, Ms. Cameron's beneficial ownership stands at 48,085.657 shares.
- The deferred stock units are scheduled to vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service.
- Upon vesting, the units will be settled in shares of common stock.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive signal, as it indicates a director's increased equity stake in the company, aligning their interests with shareholders, even if it's a compensation grant rather than an open market purchase.
Positives
- A Director's acquisition of shares, even through a grant, can signal confidence in the company's future prospects and alignment with shareholder interests.
Future Outlook
The deferred stock units are set to vest on the day prior to the first annual stockholders' meeting of Aramark occurring after the grant date, contingent upon the Director's continued service. Upon vesting, these units will convert into common stock.
Industry Context
StockSavvy.ai notes that insider transactions, particularly acquisitions, are often monitored by investors as they can provide insights into management's perception of the company's value and future performance. While this is a grant, it still increases the director's stake.
Comparison to Industry Standards
- This Form 4 filing reports a routine grant of deferred stock units to a director as part of compensation, which is a common practice across publicly traded companies in various industries, including the food services and facilities management sector where Aramark operates.
- The specific value and number of units granted are typically determined by the company's compensation committee based on factors such as director tenure, responsibilities, and overall compensation philosophy, which varies by company and is not directly comparable to specific peer companies without further context on Aramark's compensation structure relative to competitors like Compass Group PLC or Sodexo S.A.
Stakeholder Impact
- Shareholders may view the increased beneficial ownership by a director as a positive sign of management's commitment and confidence in the company's future.
Next Steps
- The deferred stock units will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service.
Key Dates
| Date | Description |
|---|---|
| 02/03/2026 | Date of transaction for the acquisition of deferred stock units. |
| 02/04/2026 | Date the Statement of Changes in Beneficial Ownership was signed. |
Recommendation
holdThis Form 4 filing details a routine grant of deferred stock units to a director, which is a common compensation practice. While it increases insider ownership, it does not provide new fundamental information about the company's operational performance or strategic direction that would warrant a change in investment recommendation. Investors should consider this as a minor positive signal within the broader context of Aramark's financial health and market position.
Keywords
Aramark, ARMK, Form 4, Insider Transaction, Stock Acquisition, Director, Deferred Stock Units, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.